Govt Job for Pharmacists in Primary Health Centers

The following qualifications are advised to apply as the vacant (10) Pharmacist posts in the Primary Health Centers of Vellore Health District will be filled temporarily on contractual basis only for a period of six months only.

Post : Pharmacist

Qualification :D.Pharm
Salary : Rs 12,000/- pm

Eligibility :
1. A Diploma in Pharmacy
2. Must have registered with the Tamil Nadu Pharmacy Council and must keep the registration alive by renewing it regularly every year.

Age : On 01.07.2021 over 18 years

Address to which the application should be sent in person or by registration : at the Office of the Deputy Director of Health Services, Vellore – 9.  .
The last day to apply is 05.08.2021 by 5 pm

Related Posts

WHO launches new primary health care course to strengthen health systems globally

Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

WHO launches new primary health care course to strengthen health systems globally

WHO launches new primary health care course to strengthen health systems globally

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert